Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
Clinical trial NCT02226003 · COMPLETED
Trial details
- NCT number
- NCT02226003
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-23
- Primary completion
- 2016-02-23
- Enrollment
- 291
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.